GLP-1 TV · Patient story · views checked Oct 2026
I've Lost 60 Pounds In 6 Months! An Update On My Weightloss Journey #zepbound
Our summary
Sarah, who runs the realiteasquad channel, says she has lost 60 lbs in 6 months on tirzepatide. She started on January 23rd 2024 with Mounjaro and has since switched to Zepbound. She explains that both are the same drug from the same manufacturer, Eli Lilly, and that Zepbound is the version FDA approved for weight loss. She says the medication has changed her relationship with food, though she has had side effects, mainly constipation, which she manages by staying hydrated. She advises talking to your doctor before taking any supplements for side effects.
One person's experience, in their words. Not medical advice.
Where Zepbound costs least today
The three cheapest partner programs for Zepbound, all in per month, checked weekly. Brand Zepbound and compounded versions are different products; each row says which it is.
What else the video covers
Most of the video responds to critical comments on her Instagram post about the 60 lb milestone. To the comment "eat less and do more," she replies that she is now eating less and doing more, but says she has learned from medical experts that obesity involves medical reasons that make this harder than it sounds. She describes the medication as paving the road, not a quick fix, and says the work of losing weight is still hers. To the comment that people always pay for their choices, she says she sees her doctor every couple of months for blood work and to discuss her rate of loss and any dose changes. She says her general practitioner and gastroenterologist both supported the decision, and the gastroenterologist told her to watch for GI side effects. She lists health risks of obesity that her doctors raised, including certain cancers, high blood pressure, cardiac disease, type 2 diabetes, arthritis, sleep apnea and strokes.
On long-term plans, she says she is not sure and is mentally prepared to stay on the medication for life. She says people in the social media groups she belongs to often enter a maintenance phase at goal weight, lowering the dose or spacing out injections to every 10 days, two weeks or monthly. She is about 30 lbs from her goal weight and plans to make a plan with her doctor.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:30 Sarah says she began on Mounjaro on January 23rd 2024, then switched to Zepbound, which she describes as the same tirzepatide from Eli Lilly.
- 1:00 She reports losing 60 lbs in 6 months and says constipation is her main side effect, handled by staying hydrated.
- 2:32 She answers the "eat less and do more" comment by saying she is doing both now, and that she sees the medication as support, not a quick fix.
- 3:34 She says she sees her doctor every couple of months for blood work, and that her GP and gastroenterologist both supported starting.
- 5:05 She says her doctors pointed to obesity-related health risks, such as high blood pressure, type 2 diabetes and sleep apnea.
- 5:36 She is unsure about her long-term plan, is prepared to stay on the medication for life, and describes maintenance as lower or less frequent dosing.
Key moments
From the creator's own chapters. Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Zepbound
- Point in the journey
- Month 6
- Weight loss mentioned
- 60 lb, in the title
- Who is speaking
- Patient
Questions this video answers
How much weight did she lose on Zepbound and Mounjaro in 6 months?
Sarah says she lost 60 lbs in 6 months on tirzepatide. She started with Mounjaro on January 23rd 2024 and later switched to Zepbound.
Are Mounjaro and Zepbound the same drug?
According to Sarah, they are the same drug, tirzepatide, made by Eli Lilly. She says Zepbound is the version FDA approved to treat weight loss.
What side effects does she report on Zepbound?
Sarah says she has had constipation and has to stay hydrated to stay ahead of it. She says her gastroenterologist told her GI issues are the most common side effects and advises talking to your doctor before taking supplements.
What happens after reaching goal weight on tirzepatide?
Sarah says she is not sure of her own plan and is prepared to stay on it for life. She says people in her online groups often enter a maintenance phase with a lower dose or longer gaps between injections, such as every 10 days, two weeks or monthly.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
I Tried Zepbound For Weight Loss - 10 Month Update 💉Dani, a creator who posts weekly about GLP-1 medications, gives a 10 month update on taking Zepbound for weight loss.
Zepbound (tirzepatide) My 100+ pounds weight loss journey! #glp1 #zepboundMs. Toy, who runs the channel Ms. Toy The Review, introduces her weight loss story with Zepbound (tirzepatide).
Losing 100 Pounds! | 2 Years On Zepbound - The Good, The Bad, & The UglySarah, who runs the realiteasquad channel, gives a two-year update on her weight loss with Zepbound.
🎯 Why Mounjaro, Ozempic & Zepbound Stop Working (And What to Do) #GLP1 #tirzepatide #zepboundIn this video, Zuri of the channel Learn with Zuri says she has compiled the top reasons weight loss can stall while taking tirzepatide or semaglutide, which she names by brand as Mounjaro, Zepbound and Ozempic.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs
Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on two hormone receptors, GIP and GLP-1. The FDA label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-5 trial it produced 20.2% average weight loss at 72 weeks against 13.7% for semaglutide. Lilly sells it self-pay from $299 a month.
- Zepbound vs Mounjaro: one molecule, two labels, and why the label sets your price
Zepbound and Mounjaro are both tirzepatide, made by Lilly, injected weekly at the same six doses from 2.5 to 15 mg. Mounjaro is approved for type 2 diabetes and Lilly's own site says it is not a weight-loss drug; Zepbound is the same molecule approved for obesity and sleep apnoea. That label decides everything downstream: insurers cover Mounjaro for diabetes and refuse it for weight, Zepbound is the box a plan can cover for weight, and Zepbound's cash price runs $299 to $699 by dose, while LillyDirect sells Mounjaro from $499 a month at every strength, against a list price of $1,112.16 per fill.
Find more like it
Side effectsWeigh-in and results
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.